Home Viral Vector and Vaccine Services Viral Vector and Vaccine cGMP Production
Cells connecting

Viral Vector and Vaccine cGMP Production

End-to-End Services

As a leading CDMO with world-class cGMP-compliant facilities, FUJIFILM Diosynth Biotechnologies offers end-to-end services for the production of viral vectors and recombinant vector vaccines.

Fully Equipped Facilities, Leading Edge Technology

Our facilities located in College Station, Texas, USA, are fully equipped to support virology and process development activities needed for the creation, development and scale up of adherent and suspension cell culture processes. Our analytical laboratories cater for the development of analytical methods for product characterization and QC testing for batch release.

Our GMP facilities represent the leading edge of mobile clean room (MCR) and single-use technology implementation, able to support cGMP manufacturing of drug substance and drug product for pre-clinical, clinical and commercial supply.

We develop adherent and suspension cell culture processes using CellSTACK/HYPERStack platforms and single-use bioreactors from 10L to 2,000L scale.

Local Service, Global Partnership

expanded global footprint

We are expanding our global footprint, establishing hubs in the UK and Watertown, Massachusetts, USA, which will be able to perform process development and cGMP manufacturing for pre-clinical and early phase/first in human clinical supply.  Already committed investment plans mean that in the future we will also be able to support late phase clinical and commercial manufacturing in the UK.

 

Fill/Finish Capabilities

Our drug product manufacturing (fill/finish) facility in College Station, Texas, USA, contains two Vanrx SA25 Aseptic Fill Workcells, each housed in a Generation 3 Mobile Clean Room (MCR).  The state-of-the-art integrated, touchless robotic systems deliver the highest standards of precision and containment, with minimal product losses, providing high value, cGMP compliant products, without compromising product quality attributes.

Please see Extended Full Services, for more details about our drug product manufacturing (fill/finish) capabilities including formulation development, vial filling, stability testing and release of licensed products.

Brochure corporate capabilities